142 related articles for article (PubMed ID: 9405425)
1. Separate domains of the human fas ligand dictate self-association and receptor binding.
Orlinick JR; Elkon KB; Chao MV
J Biol Chem; 1997 Dec; 272(51):32221-9. PubMed ID: 9405425
[TBL] [Abstract][Full Text] [Related]
2. Binding of the intracellular Fas ligand (FasL) domain to the adaptor protein PSTPIP results in a cytoplasmic localization of FasL.
Baum W; Kirkin V; Fernández SB; Pick R; Lettau M; Janssen O; Zörnig M
J Biol Chem; 2005 Dec; 280(48):40012-24. PubMed ID: 16204241
[TBL] [Abstract][Full Text] [Related]
3. Fas ligand (CD178) cytoplasmic tail is a positive regulator of Fas ligand-mediated cytotoxicity.
Jodo S; Pidiyar VJ; Xiao S; Furusaki A; Sharma R; Koike T; Ju ST
J Immunol; 2005 Apr; 174(8):4470-4. PubMed ID: 15814666
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of Fas ligand by shedding.
Tanaka M; Itai T; Adachi M; Nagata S
Nat Med; 1998 Jan; 4(1):31-6. PubMed ID: 9427603
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Fas (Apo-1, CD95)-Fas ligand interaction.
Schneider P; Bodmer JL; Holler N; Mattmann C; Scuderi P; Terskikh A; Peitsch MC; Tschopp J
J Biol Chem; 1997 Jul; 272(30):18827-33. PubMed ID: 9228058
[TBL] [Abstract][Full Text] [Related]
6. Fas ligand is localized to membrane rafts, where it displays increased cell death-inducing activity.
Cahuzac N; Baum W; Kirkin V; Conchonaud F; Wawrezinieck L; Marguet D; Janssen O; Zörnig M; Hueber AO
Blood; 2006 Mar; 107(6):2384-91. PubMed ID: 16282344
[TBL] [Abstract][Full Text] [Related]
7. Cloning and expression of a short Fas ligand: A new alternatively spliced product of the mouse Fas ligand gene.
Ayroldi E; D'Adamio F; Zollo O; Agostini M; Moraca R; Cannarile L; Migliorati G; Delfino DV; Riccardi C
Blood; 1999 Nov; 94(10):3456-67. PubMed ID: 10552956
[TBL] [Abstract][Full Text] [Related]
8. Cloning and potential utility of porcine Fas ligand: overexpression in porcine endothelial cells protects them from attack by human cytolytic cells.
Tsuyuki S; Kono M; Bloom ET
Xenotransplantation; 2002 Nov; 9(6):410-21. PubMed ID: 12371937
[TBL] [Abstract][Full Text] [Related]
9. Humanization and epitope mapping of neutralizing anti-human Fas ligand monoclonal antibodies: structural insights into Fas/Fas ligand interaction.
Nisihara T; Ushio Y; Higuchi H; Kayagaki N; Yamaguchi N; Soejima K; Matsuo S; Maeda H; Eda Y; Okumura K; Yagita H
J Immunol; 2001 Sep; 167(6):3266-75. PubMed ID: 11544314
[TBL] [Abstract][Full Text] [Related]
10. Expression of the functional soluble form of human fas ligand in activated lymphocytes.
Tanaka M; Suda T; Takahashi T; Nagata S
EMBO J; 1995 Mar; 14(6):1129-35. PubMed ID: 7536672
[TBL] [Abstract][Full Text] [Related]
11. Significant inhibition of human CD8(+) cytotoxic T lymphocyte-mediated xenocytotoxicity by overexpression of the human decoy Fas antigen.
Kawamoto K; Tanemura M; Nishida T; Fukuzawa M; Ito T; Matsuda H
Transplantation; 2006 Mar; 81(5):789-96. PubMed ID: 16534484
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the ligand binding site in Fas (CD95) by site-directed mutagenesis and comparison with TNFR and CD40.
Starling GC; Kiener PA; Aruffo A; Bajorath J
Biochemistry; 1998 Mar; 37(11):3723-6. PubMed ID: 9521690
[TBL] [Abstract][Full Text] [Related]
13. Identification of amino acid residues important for ligand binding to Fas.
Starling GC; Bajorath J; Emswiler J; Ledbetter JA; Aruffo A; Kiener PA
J Exp Med; 1997 Apr; 185(8):1487-92. PubMed ID: 9126929
[TBL] [Abstract][Full Text] [Related]
14. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster.
Lynch DH; Watson ML; Alderson MR; Baum PR; Miller RE; Tough T; Gibson M; Davis-Smith T; Smith CA; Hunter K
Immunity; 1994 May; 1(2):131-6. PubMed ID: 7889405
[TBL] [Abstract][Full Text] [Related]
15. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
Takahashi T; Tanaka M; Brannan CI; Jenkins NA; Copeland NG; Suda T; Nagata S
Cell; 1994 Mar; 76(6):969-76. PubMed ID: 7511063
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes.
Cippitelli M; Fionda C; Di Bona D; Di Rosa F; Lupo A; Piccoli M; Frati L; Santoni A
J Immunol; 2002 Feb; 168(3):1154-66. PubMed ID: 11801650
[TBL] [Abstract][Full Text] [Related]
17. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
18. The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells.
Chow WA; Fang JJ; Yee JK
J Immunol; 2000 Apr; 164(7):3512-8. PubMed ID: 10725705
[TBL] [Abstract][Full Text] [Related]
19. A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.
Del-Rey M; Ruiz-Contreras J; Bosque A; Calleja S; Gomez-Rial J; Roldan E; Morales P; Serrano A; Anel A; Paz-Artal E; Allende LM
Blood; 2006 Aug; 108(4):1306-12. PubMed ID: 16627752
[TBL] [Abstract][Full Text] [Related]
20. Agonist antibody and Fas ligand mediate different sensitivity to death in the signaling pathways of Fas and cytoplasmic mutants.
Thilenius AR; Braun K; Russell JH
Eur J Immunol; 1997 May; 27(5):1108-14. PubMed ID: 9174599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
